Metraipolis › archive › dc_00834164cb73
Exposure to Bisphenol A and Bisphenol S and Incident Type 2 Diabetes: A Case-Cohort Study in the French Cohort D.E.S.I.R — Europe PMC PMID:31663775
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/31663775
- DOI
- 10.1289/ehp5159
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-10T05:19:11.911Z
- SHA-256 of the archived text
3a8026a223a53419e8ee9dcaeddef620425f1b335acd10c54ea5a16221a7328b- Stable URL of this page
https://metraipolis.com/documento/dc_00834164cb73
How to cite
Exposure to Bisphenol A and Bisphenol S and Incident Type 2 Diabetes: A Case-Cohort Study in the French Cohort D.E.S.I.R — Europe PMC PMID:31663775 — Europe PMC (en), https://europepmc.org/article/MED/31663775 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_00834164cb73 (Metraipolis archive dc_00834164cb73, sha256 3a8026a223a53419e8ee9dcaeddef620425f1b335acd10c54ea5a16221a7328b)
BibTeX
@misc{dc00834164cb73,
title = {Exposure to Bisphenol A and Bisphenol S and Incident Type 2 Diabetes: A Case-Cohort Study in the French Cohort D.E.S.I.R — Europe PMC PMID:31663775},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/31663775},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_00834164cb73; sha256 3a8026a223a53419e8ee9dcaeddef620425f1b335acd10c54ea5a16221a7328b},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31663775. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: The question of whether exposure to bisphenol A (BPA) contributes to the development of type 2 diabetes is still unresolved. Most epidemiological evidence on the association between BPA and diabetes is from cross-sectional studies or longitudinal studies with single urinary measurements. No prospective study has examined exposure to BPA analogs such as bisphenol S (BPS) in relation to incident type 2 diabetes. Objectives: We aimed to investigate whether exposure to BPA and BPS, assessed at up to two time points, was associated with the incidence of type 2 diabetes. Methods: We performed a case-cohort study on 755 participants without diabetes at baseline and followed-up over 9 y as part of the French prospective cohort Data from an Epidemiological Study on the Insulin Resistance Syndrome (D.E.S.I.R.). BPA-glucuronide (BPA-G) and BPS-glucuronide (BPS-G) were assessed in fasting spot urine samples collected during the health examinations at baseline and 3 y later. Associations with incident diabetes were examined using Prentice-weighted Cox regression models adjusted for potential confounders. Results: A total of 201 incident cases of type 2 diabetes were diagnosed over the follow-up, including 30 in the subcohort. Compared with participants with the lowest average BPA exposure (below the first quartile), participants in the second, third, and fourth quartile groups of exposure had a near doubling of the risk of type 2 diabetes, with a hazard ratio (HR) = 2.56 (95% CI: 1.16, 5.65), 2.35 (95% CI: 1.07, 5.15), and 1.56 (95% CI: 0.68, 3.55), respectively. The detection of BPS-G in urine at one or both time points was associated with incident diabetes, with an HR = 2.81 (95% CI: 1.74, 4.53). Discussion: This study shows positive associations between exposure to BPA and BPS and the incidence of type 2 diabetes, independent of traditional diabetes risk factors. Our results should be confirmed by recent, population-based observational studies in different populations and settings. Overall, these findings raise concerns about using BPS as a BPA substitute. Further research on BPA analogs is warranted. https://doi.org/10.1289/EHP5159. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Environmental health perspectives, 2019 (prima pubblicazione 2019-10-30). Identificativi: PMID 31663775 · PMCID PMC6867193 · DOI 10.1289/ehp5159. Pagina: https://europepmc.org/article/MED/31663775 — https://doi.org/10.1289/ehp5159. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-10T05:16:32.045Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.